Genprex grabs funding from Inception-led round

Genprex, a biopharmaceutical company focused on developing immunogene therapy treatments, has secured undisclosed funding. Inception Capital Management led the round. In addition to the funding, the company has appointed Dr. Julien Pham as chief operating officer. Previously, Pham worked at RubinconMD where he was the founder and chief medical officer.

North AmericaUSBriefs